Login / Signup

Placental Inflammation Significantly Correlates with Reduced Risk for Retinopathy of Prematurity.

Leah A OwenCharles ZhangKinsey ShirerLara CarrollBlair WoodKathryn SzczotkaColette CorniaChristopher StubbenCamille FungChristian C YostLakshmi D KatikaneniMargaret M DeAngelisJessica Comstock
Published in: The American journal of pathology (2023)
Retinopathy of prematurity (ROP), a blinding condition affecting preterm infants, is an interruption of retinal vascular maturation which is incomplete when born preterm birth. Although ROP demonstrates delayed onset following preterm birth, representing a window for therapeutic intervention, we cannot cure or prevent this disease. The in-utero environment, including placental function, is increasingly recognized for contributions to preterm infant disease risk. Herein, we identify a protective association between acute placental inflammation and preterm infant ROP development using logistic regression, with the most significant association found for infants without gestational exposure to maternal preeclampsia and those with earlier preterm birth. Expression analysis of proteins with described ROP risk associations demonstrates significantly decreased placental HTRA1 and FABP4 protein expression for infants with acute placental inflammation compared to those without. Within the post-natal peripheral circulation, HTRA1 and VEGFA demonstrate inverse longitudinal trends for infants born in the presence compared to absence of acute placental inflammation. An agnostic approach, including whole transcriptome and differential methylation placental analysis, further identifies novel mediators and pathways that may underly protection. Taken together, these data build on emerging literature showing a protective association between acute placental inflammation and ROP development and identifies novel mechanisms that may inform postnatal risk associations in preterm infants.
Keyphrases